✦ LIBER ✦

CD40 ligand-independent B cell activation revealed by CD40 ligand-deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation

✍ Scribed by Peter Lane; Corinne Burdet; Fiona McConnell; Antonio Lanzavecchia; Elisabetta Padovan

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 867 KB
Volume: 25
Category: Article
ISSN: 0014-2980
DOI: 10.1002/eji.1830250646

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Co-stimulation by anti-immunoglobulin is

Co-stimulation by anti-immunoglobulin is required for B cell activation by CD40Llow T cells

✍ Johanne Poudrier; Trevor Owens 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 887 KB

Cleavage of membrane-bound CD40 ligand i

Cleavage of membrane-bound CD40 ligand is not required for inducing B cell proliferation and differentiation

✍ Fabienne Pietravalle; Sybille Lecoanet-Henchoz; Jean-Pierre Aubry; Greg Elson; J 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB

Activated human T cells express a ligand

Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes

✍ Peter Lane; André Traunecker; Sabine Hubele; Seiji Inui; Antonio Lanzavecchia; D 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 614 KB

## Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes To identify the ligand for the B cell-associated antigen CD40, we constructed a chimeric immunoglobulin molecule where the extracellular porti

B cells regulate expression of CD40 liga

B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40

✍ Cees van Kooten; Claude Gaillard; Jean-Pierre Galizzi; Patrice Hermann; François 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

Ligation of B7 with CD28/CTLA-4 on T cel

Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells

✍ Mark de Boer; Ahmad Kasran; Jaap Kwekkeboom; Hugo Walter; Peter Vandenberghe; Ja 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 621 KB

Anti-CD3-based bispecific antibody desig

Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms

✍ Brian K. Link; Sheri A. Kostelny; Michael S. Cole; William P. Fusselman; J. Yun 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 107 KB 👁 2 views

## Anti -CD3 ؋ anti-B-cell antigen bispecific monoclonal antibodies (bsAbs) can redirect T-cell-mediated lysis toward malignant B cells. Clinical trials with CD3-based bsAbs have shown toxicity in patients which is likely related to nonspecific T-cell activation and targeting. Our current studies